NASDAQ Biotechnology Total Retu XNBI Indice
4554.45 USD
{{ price }}
1.850359%
{{change_pct}}%
PAESE
stati Uniti
Borsa valori
Nasdaq GIDS
MIN - MAX [24 ore]
4436.63
-
4556.71 USD
Numero di componenti
190
NASDAQ Biotechnology Total Retu Grafico dei prezzi
Top 5 Vincitori delle Ultime 24 Ore
| DBVT | DBV | +19.2% | |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics | +14.69% | |
| SGMO | Sangamo Therapeutics | +14.58% | |
| CHRS | Coherus BioSciences | +12.91% | |
| PACB | Pacific Biosciences of California | +12.39% |
Top 5 Perdenti delle Ultime 24 Ore
| NSTG | NanoString | -37.43% | |
|---|---|---|---|
| BLUE | bluebird bio | -4.19% | |
| AMRN | Amarin | -2.26% | |
| AMPH | Amphastar Pharmaceuticals | -1.73% | |
| ESPR | Esperion Therapeutics | -1.42% |
NASDAQ Biotechnology Total Retu XNBI PANORAMICA FINANZIARIA E DI TRADING
| NASDAQ Biotechnology Total Retu Prezzo dell'Indice | 4554.45 USD |
| Chiusura Precedente | 4472.96 USD |
| Apertura | 4476.26 USD |
| Prezzo di Acquisto | 0 USD x 0 |
| Prezzo di Vendita | 0 USD x 0 |
| Variazione Giornaliera | 4464.53 - 4532.84 USD |
| Variazione a 52 Settimane | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Volume Medio | N/A |
Informazioni di trading
NASDAQ Biotechnology Total Retu Storico dei prezzi dell'Indice
| Massimo a 52 Settimane | 4532.84 USD |
| Minimo a 52 Settimane | 4464.53 USD |
| Media Mobile a 50 Giorni | N/A |
| Media Mobile a 200 Giorni | N/A |
XNBI Statistiche dell'indice
| Volume Medio (3 Mesi) | N/A |
| Vol. Medio Giornaliero (10 Giorni) | N/A |
D&R per l'Indice NASDAQ Biotechnology Total Retu
Qual è il prezzo attuale dell'Indice XNBI?
Il prezzo dell'Indice NASDAQ Biotechnology Total Retu XNBI oggi è di 4554.45 USD.
Come acquistare l'Indice NASDAQ Biotechnology Total Retu?
Puoi acquistare l'indice XNBI sulla borsa Nasdaq GIDS. Contatta il tuo consulente finanziario per selezionare un broker.
Qual è la sigla borsistica dell'Indice NASDAQ Biotechnology Total Retu?
La sigla (o ticker) dell'Indice NASDAQ Biotechnology Total Retu è XNBI.
Quanti componenti contiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu contiene 190 componenti.
A quale paese appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento a United States.
A quale borsa appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento alla borsa Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPONENTI
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $305.7 — |
-0.4
|
$164.22B — | $1.91M — | $300.1 — | $306.76 — | $164.22B — | 40.49 | $7.55 — |
| Gilead Sciences GILD | $111.89 — |
+0.55
|
$139.49B — | $7.44M — | $110.47 — | $112.01 — | $139.49B — | 294.44 | $0.38 — |
| Vertex Pharmaceuticals Incorporated VRTX | $483.49 — |
-0.26
|
$124.16B — | $987.24K — | $480.43 — | $487.93 — | $124.16B — | 0 | -$2.08 — |
| Regeneron Pharmaceuticals REGN | $625.6 — |
+1.39
|
$68.39B — | $898.4K — | $610.1 — | $628 — | $68.39B — | 16.32 | $38.32 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $266.83 — |
+4.33
|
$34.54B — | $874.93K — | $252.07 — | $267.29 — | $34.54B — | 0 | -$2.17 — |
| Biogen BIIB | $131.32 — |
-0.54
|
$19.22B — | $1.94M — | $128.75 — | $133.97 — | $19.22B — | 11.74 | $11.18 — |
| United Therapeutics UTHR | $312.26 — |
+1.75
|
$14.02B — | $346.91K — | $303.16 — | $313.41 — | $14.02B — | 12.67 | $24.64 — |
| Insmed Incorporated INSM | $73.44 — |
+2
|
$13.29B — | $2.36M — | $70.3 — | $73.45 — | $13.29B — | 0 | -$5.57 — |
| BioMarin Pharmaceutical BMRN | $68.32 — |
+0.56
|
$13.03B — | $1.4M — | $67.47 — | $69.87 — | $13.03B — | 30.91 | $2.21 — |
| Illumina ILMN | $81.88 — |
+4.45
|
$12.97B — | $1.9M — | $77.99 — | $82.76 — | $12.97B — | 0 | -$7.69 — |
| Incyte INCY | $62.33 — |
+2.33
|
$12.06B — | $1.97M — | $60.27 — | $62.53 — | $12.06B — | 415.53 | $0.15 — |
| Neurocrine Biosciences NBIX | $108.31 — |
+1.22
|
$10.8B — | $1.42M — | $105.78 — | $108.43 — | $10.8B — | 33.02 | $3.28 — |
| Exelixis EXEL | $37.04 — |
+1.79
|
$10.37B — | $1.81M — | $35.82 — | $37.14 — | $10.37B — | 21.04 | $1.76 — |
| Bio-Techne TECH | $58.38 — |
+1.8
|
$9.23B — | $1.46M — | $56.82 — | $58.64 — | $9.23B — | 59.57 | $0.98 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Qiagen QGEN | $40.02 — |
+1.32
|
$8.65B — | $1.44M — | $39.33 — | $40.19 — | $8.65B — | 105.31 | $0.38 — |
| Halozyme Therapeutics HALO | $63.02 — |
+1.86
|
$7.79B — | $1.41M — | $61.54 — | $63.14 — | $7.79B — | 18.37 | $3.43 — |
| Jazz Pharmaceuticals JAZZ | $126.44 — |
+1.16
|
$7.68B — | $995.06K — | $123.81 — | $127.83 — | $7.68B — | 14.61 | $8.65 — |
| Repligen RGEN | $130.92 — |
+1.88
|
$7.35B — | $594.12K — | $124.99 — | $133.3 — | $7.35B — | 0 | -$0.46 — |
- {{ link.label }} {{link}}